In 1927 Landsteiner and Levine reported the discovery in human blood of the antigen P. Since this time, the corresponding antibody has been detected frequently, but, in most of the sera described, is weak both in titre and avidity, and requires a special technique in order to demonstrate its presence. For this reason the unexpected finding of a powerful naturally occurring antibody, anti-P, in the serum of a patient is of interest. The following is a description of the reactions of the antibody which we found during routine work.
In 1927 Landsteiner and Levine reported the discovery in human blood of the antigen P. Since this time, the corresponding antibody has been detected frequently, but, in most of the sera described, is weak both in titre and avidity, and requires a special technique in order to demonstrate its presence. For this reason the unexpected finding of a powerful naturally occurring antibody, anti-P, in the serum of a patient is of interest. The following is a description of the reactions of the antibody which we found during routine work. Gene Frequency of Antigen.-The serum of S. W. W. was tested against 92 samples of group A Rh-positive blood chosen at random. Of these, 22 were found to be compatible and 70 were not compatible. The gene frequency corresponding to the antigen which was reacting with the antibody in S. W. W.'s serum and the gene frequency of its presumed allelomorph was worked out using the method described in M.R.C. Memorandum No. 27 (Mollison, Mourant, and Race, 1952) . These worked out as 0.51 and 0.49 respectively. The panel of blood used is too small for accurate determination of the gene frequencies, but, as the gene frequencies of P and p are 0.4901 and 0.5099 respectively, the results suggested that we might be dealing with the P blood group and that the antibody was anti-P.
Tests Against Panel of Known Blood Groups.-
The serum of S. W. W. was tested against the red cells of 19 individuals in whom the ABO, MNS, P, Lewis, Rh, Duffy, and Kell blood groups were known. Fourteen were P positive, and the cells of these agglutinated with the serum of S. W. W. Four of the panel were P negative and the serum did not agglutinate the cells of these individuals. The red cells of one of the donors on the panel, A. D., who had been notified as " P negative," were agglutinated by the serum of S. W. W. Accordingly, the blood of A. D. was sent to the Commonwealth Serum Laboratories, Melbourne, so that the cells could be retyped by Mr. R. T. Simmons, who confirmed that A. D. did in fact belong to blood group P: the initial error in grouping the cells was most probably due to low potency anti-P sera. The serum of S. W. W. was then retested against known P-positive and P-negative blood in the Commonwealth Serum Laboratories. The serum agglutinated all "P-positive" cells and failed to agglutinate all "P-negative" cells.
Family Studies. The cells of A. W. with the absorbed antibodies were then shaken in saline and the antibody was eluted in the manner described by Mollison. The eluate agglutinated two specimens of P-positive cells, whereas the absorbed serum failed to agglutinate the same cells. It is possible, therefore, to obtain this antibody in a pure form.
Discussion
Approximately 75% of white people are P positive, belonging to the genotype PP or Pp. The remainder are P negative and belong to the genotype pp. The gene p is allelomorphic to P. Due to the fact that transfusion is so widely practised, and as anti-P serum is not available in adequate quantity for the routine grouping of donors and recipients, many P-negative people are transfused with P-positive blood. As a result these recipients could develop anti-P. Transfusion reactions from this cause have indeed been reported. However, most anti-P sera are of low titre and the reactions are generally mild.
The present case indicates that the antibody anti-P may on rare occasions be present in sufficient titre to be a cause of a severe transfusion reaction. Recently Kolbl and Speiser (1953) have reported a case in which the maternal anti-P antibody had a titre of 1 in 16 in human serum at body temperature. The case history of her infant suggests that it suffered from erythroblastosis foetalis due to the presence of anti-P in the maternal blood as a result of maternal immunization.
The need for careful routine cross-typing of donor cells against patient's serum is borne out by this case. Atypical isohaemoglutins occur rarely, but they make their appearance with dramatic suddenness at inconvenient times and it is therefore essential that a rigid technique should always be followed of grouping and cross-typing each patient's serum against each blood bottle issued to him before notifying it as compatible.
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